<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15/A
AMENDMENT 1
Certification and Notice of Termination of Registration under Section 12(g)
of the Securities Exchange Act of 1934 or Suspension of Duty to File Reports
Under Sections 13 and 15(d) of the Securities Exchange Act of 1934.
Commission File Number 1-111150
Imagyn Medical Technologies, Inc.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
1 Park Plaza, Suite 1100, Irvine, California 92614
(949) 809-0800
---------------------------------------------------------------------------
(Address, including zip code, and telephone number, including area code, of
registrant's principal executive offices)
Common Stock
--------------------------------------------------------
(Title of each class of securities covered by this Form)
None
---------------------------------------------------------------------------
(Titles of all other classes of securities for which a duty to file reports
under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) [X] Rule 12h-3(b)(1)(ii) [ ]
Rule 12g-4(a)(1)(ii) [ ] Rule 12h-3(b)(2)(i) [ ]
Rule 12g-4(a)(2)(i) [ ] Rule 12h-3(b)(2)(ii) [ ]
Rule 12g-4(a)(2)(ii) [ ] Rule 15d-6 [ ]
Rule 12h-3(b)(1)(i) [X]
Approximate number of holders of record as of the certification or notice date:
75
Pursuant to the requirements of the Securities Exchange Act of 1934,
Imagyn Medical Technologies, Inc. has caused this certification/notice to be
signed on its behalf by the undersigned duly authorized person.
DATE: November 5, 1999 By: /s/ Michael A. Montevideo
---------------------------------
Name: Michael A. Montevideo
Title: Senior Vice President and
Chief Financial Officer
